High density is a property of slow-cycling and treatment-resistant human glioblastoma cells

Hanna Sabelström, David A. Quigley, Trenten Fenster, Daniel J. Foster, Clara A.M. Fuchshuber, Supna Saxena, Edith Yuan, Nan Li, Francesca Paterno, Joanna J. Phillips, Charles David James, Börje Norling, Mitchel S. Berger, Anders I. Persson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Slow-cycling and treatment-resistant cancer cells escape therapy, providing a rationale for regrowth and recurrence in patients. Much interest has focused on identifying the properties of slow-cycling tumor cells in glioblastoma (GBM), the most common and lethal primary brain tumor. Despite aggressive ionizing radiation (IR) and treatment with the alkylating agent temozolomide (TMZ), GBM patients invariably relapse and ultimately succumb to the disease. In patient biopsies, we demonstrated that GBM cells expressing the proliferation markers Ki67 and MCM2 displayed a larger cell volume compared to rare slow-cycling tumor cells. In optimized density gradients, we isolated a minor fraction of slow-cycling GBM cells in patient biopsies and tumorsphere cultures. Transcriptional profiling, self-renewal, and tumorigenicity assays reflected the slow-cycling state of high-density GBM cells (HDGCs) compared to the tumor bulk of low-density GBM cells (LDGCs). Slow-cycling HDGCs enriched for stem cell antigens proliferated a few days after isolation to generate LDGCs. Both in vitro and in vivo, we demonstrated that HDGCs show increased treatment-resistance to IR and TMZ treatment compared to LDGCs. In conclusion, density gradients represent a non-marker based approach to isolate slow-cycling and treatment-resistant GBM cells across GBM subgroups.

Original languageEnglish (US)
Pages (from-to)76-86
Number of pages11
JournalExperimental Cell Research
Volume378
Issue number1
DOIs
StatePublished - May 1 2019

Funding

We thank patients for giving their consent and the staff at the UCSF Neurosurgery Tissue Core for providing human GBM biopsies from patients undergoing surgery. We also thank Eunice Wan for excellent assistance with microarray processing. A.I.P. acknowledges financial support from NIH / NINDS ( U54CA163155 , R21NS088114 ), American Brain Tumor Association Collaboration Grant supported by Humor to Fight the Tumor, the Loglio Collaborative , the TDC Foundation , and the Guggenhime Endowment Fund . H.S. was supported by fellowships from Vetenskapsrådet (the Swedish Research Council ), the European Molecular Biology Organization (EMBO), the Foundation BLANCEFLOR Boncompagni Ludovisi , and the ABTA Basic Research Fellowship in memory of Joel A. Gingras, Jr. J.J.P acknowledges support from NIH/NINDS ( 1R01 NS081117 ). We thank patients for giving their consent and the staff at the UCSF Neurosurgery Tissue Core for providing human GBM biopsies from patients undergoing surgery. We also thank Eunice Wan for excellent assistance with microarray processing. A.I.P. acknowledges financial support from NIH/NINDS (U54CA163155, R21NS088114), American Brain Tumor Association Collaboration Grant supported by Humor to Fight the Tumor, the Loglio Collaborative, the TDC Foundation, and the Guggenhime Endowment Fund. H.S. was supported by fellowships from Vetenskapsrådet (the Swedish Research Council), the European Molecular Biology Organization (EMBO), the Foundation BLANCEFLOR Boncompagni Ludovisi, and the ABTA Basic Research Fellowship in memory of Joel A. Gingras, Jr. J.J.P acknowledges support from NIH/NINDS (1R01 NS081117).

Keywords

  • Cancer
  • Glioblastoma
  • Glioma
  • Slow-cycling
  • Stem cell
  • Tumor

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'High density is a property of slow-cycling and treatment-resistant human glioblastoma cells'. Together they form a unique fingerprint.

Cite this